A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects

Clinical trial NCT06760455 · RECRUITING

Trial details

NCT number: NCT06760455
Sponsor: Chengdu Brilliant Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-01-10
Primary completion: 2026-01-24
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.